We have spent a couple of videos looking at safety reporting, to better understand it’s role in the MDR, the Medical Device Regulation.


Today, we’re going to tackle a broader question that also encompasses everything we’ve been talking about with safety reporting:


How is risk management related to the ISO14155?




As we discussed in one of our earlier articles on clinical evaluation, there are many processes to go through to make sure that a medical device is safe and performs as indicated throughout the lifecycle of the device. 

But how are they related and why is it important? 

The application of ISO14971 – in other words, risk assessment – to clinical investigations is described in detail in Annex H of the ISO14155

The application of risk management activities within a clinical investigation helps hazards and hazardous situations associated with the medical device to be identified and minimized from planning till closure of your clinical investigation. 


Share This Post

Other articles

Clinical Investigations

What has changed in the new ISO14155:2020 standard?

The ISO14155 provides an important guide on the use of Good Clinical Practice in clinical investigations. In the ISO14155 you’ll find the main requirements to: protect the well-being, safety and rights of human subjects in the clinical investigation; assure the scientific relevance of the investigation and the trustworthiness of its results; define what the sponsor


Harmonization EC approval process

In today’s video, I will briefly answer the following question:   “How is the approval process of Ethics Committees harmonized under the MDR?”      Transcript:   Ethics committees are responsible for evaluating a clinical investigation and determine whether ethical principles are being met. Requirements related to ethics committee composition and function are not specified in the

Scroll naar boven